id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-D-0375-0021,FDA,FDA-2004-D-0375,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,NAL-Notice of Approval,2009-01-28T05:00:00Z,2009,1,2009-01-28T05:00:00Z,,2009-01-28T17:14:08Z,E9-01803,0,0,0900006480834acb
FDA-2004-D-0375-0019,FDA,FDA-2004-D-0375,Guidance for Industry and Food and Drug Administration Staff; ``Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300; Availability,Notice,NAD-Notice of Availability of Data,2008-12-23T05:00:00Z,2008,12,2008-12-23T05:00:00Z,,2008-12-23T12:40:16Z,E8-30586,0,0,09000064807eda05
FDA-2004-D-0375-0020,FDA,FDA-2004-D-0375,Guidance for Industry and FDA Staff - Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300,Supporting & Related Material,GDL-Guidance,2008-12-23T05:00:00Z,2008,12,,,2008-12-23T12:47:23Z,,0,0,09000064807edad9
FDA-2004-D-0375-0018,FDA,FDA-2004-D-0375,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Draft Guidance for Industry and Food and Drug Administration Staff; ``Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300,Notice,N-Notice,2008-11-10T05:00:00Z,2008,11,2008-11-10T05:00:00Z,,2008-11-10T13:10:18Z,E8-26828,0,0,09000064807a13df
FDA-2004-D-0375-0013,FDA,FDA-2004-D-0375,Background Information,Supporting & Related Material,BKG-Background Material,2005-11-14T05:00:00Z,2005,11,,,2008-04-12T00:36:03Z,,0,0,0900006480473764
FDA-2004-D-0375-0006,FDA,FDA-2004-D-0375,Background Information,Supporting & Related Material,BKG-Background Material,2005-11-14T05:00:00Z,2005,11,,,2008-04-12T00:36:02Z,,0,0,090000648047375d
FDA-2004-D-0375-0001,FDA,FDA-2004-D-0375,FDA,Notice,NAD-Notice of Availability of Data,2005-11-14T05:00:00Z,2005,11,2005-11-14T05:00:00Z,2006-02-14T04:59:59Z,2008-11-07T13:05:35Z,,0,0,0900006480473751
FDA-2004-D-0375-0010,FDA,FDA-2004-D-0375,Background Information,Supporting & Related Material,BKG-Background Material,2005-11-14T05:00:00Z,2005,11,,,2008-04-12T00:36:04Z,,0,0,0900006480473761
FDA-2004-D-0375-0007,FDA,FDA-2004-D-0375,Background Information,Supporting & Related Material,BKG-Background Material,2005-11-14T05:00:00Z,2005,11,,,2008-04-12T00:36:04Z,,0,0,090000648047375e
FDA-2004-D-0375-0008,FDA,FDA-2004-D-0375,Background Information,Supporting & Related Material,BKG-Background Material,2005-11-14T05:00:00Z,2005,11,,,2008-04-12T00:36:02Z,,0,0,090000648047375f
FDA-2004-D-0375-0009,FDA,FDA-2004-D-0375,Background Information,Supporting & Related Material,BKG-Background Material,2005-11-14T05:00:00Z,2005,11,,,2008-04-12T00:36:03Z,,0,0,0900006480473760
FDA-2004-D-0375-0011,FDA,FDA-2004-D-0375,Background Information,Supporting & Related Material,BKG-Background Material,2005-11-14T05:00:00Z,2005,11,,,2008-04-12T00:36:03Z,,0,0,0900006480473762
FDA-2004-D-0375-0012,FDA,FDA-2004-D-0375,Background Information,Supporting & Related Material,BKG-Background Material,2005-11-14T05:00:00Z,2005,11,,,2008-04-12T00:36:03Z,,0,0,0900006480473763
FDA-2004-D-0375-0005,FDA,FDA-2004-D-0375,Background Information,Supporting & Related Material,BKG-Background Material,2005-11-14T05:00:00Z,2005,11,,,2008-04-12T00:36:02Z,,0,0,090000648047375c
FDA-2004-D-0375-0002,FDA,FDA-2004-D-0375,Guidance,Supporting & Related Material,GDL-Guidance,2005-11-14T05:00:00Z,2005,11,,,2008-04-12T00:36:02Z,,0,0,0900006480473755